Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome‐Mediated Suppression by Quercetin
Molecular Carcinogenesis · 2026
DOI: 10.1002/mc.70069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2026. Verfasst von Hyunjin Moon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Signal Transduction, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Ko…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Sphingosine-1-Phosphate Receptors, Quercetin, Proteasome Endopeptidase Complex. Die Arbeit nennt 29 Literaturangaben. Gefördert von: This study was supported by the Research Institute for Veterinary Science and BK21 PLUS Program for Creative Veterinary Science Research Center, Seoul National….
Abstract (Originalsprache)
Sphingosine‐1‐phosphate receptor 1 (S1PR1, also known as EDG1) is a G‐protein‐coupled receptor. Although there have been conflicting results reported, S1PR1 is generally accepted to be protumorigenic in many cancer types. However, S1PR1 has not been studied in thyroid cancer. This study aimed to investigate the biological activity of S1PR1 in thyroid cancer. S1PR1 protein levels were found to be higher in thyroid cancer tissues than adjacent normal tissues. Using an S1PR1‐GFP construct, we showed that S1PR1 is localized in the cell membrane; however, when stimulated by sphingosine‐1‐phosphate, S1PR1 appeared to move inside in the cells. In functional studies, S1PR1 knock‐out cells generated using the CRISPR/Cas9 system exhibited reduced S1PR1 activity, including colony formation, cell migration, and cell invasion. This was accompanied by the inhibition of STAT3, ERK1/2, and AKT kinase activity and cell adhesion protein expression. Furthermore, we screened several anticancer compounds to determine their effects on S1PR1 expression levels in thyroid cancer cells and found that quercetin significantly reduced S1PR1 protein levels in these cells. Overall, our results indicated that S1PR1 expression at the protein level has a positive relationship with thyroid cancer progression, as seen in other cancers. These data also suggest that quercetin is a potential anticancer drug that can target S1PR1‐positive cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Signal Transduction, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Korea.
- Department of Otolaryngology-Head and Neck Surgery, Center for Thyroid Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
ORCID-Profile: Junsun Ryu, Seung Joon Baek
Förderung
- This study was supported by the Research Institute for Veterinary Science and BK21 PLUS Program for Creative Veterinary Science Research Center, Seoul National…
Zitieren
APA
Moon, H., Li, S., Hong, Y., Ryu, C. H., Ryu, J., & Baek, S. J. (2026). Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome‐Mediated Suppression by Quercetin. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70069
Vancouver
Moon H, Li S, Hong Y, Ryu CH, Ryu J, Baek SJ. Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome‐Mediated Suppression by Quercetin. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70069
BibTeX
@article{Moon2026,
author = {Moon, Hyunjin and Li, Shiying and Hong, Yukyung and Ryu, Chang Hwan and Ryu, Junsun and Baek, Seung Joon},
title = {Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome‐Mediated Suppression by Quercetin},
journal = {Molecular Carcinogenesis},
year = {2026},
doi = {10.1002/mc.70069}
}
EUVIMED